FIELD: medicine; oncology and gynaecology.
SUBSTANCE: group of inventions refers to versions variants of composition for inhibition carcinogen-mediated breast cell transformation to cancer cells, as well as to methods of breast cancer prevention or treatment using such compositions. The composition can contain 5 wt % methylsulphonylmethane and 5 wt % juice of Morinda citrifolia fruit or its ethanolic extract, as well as water, juice of other fruits or mixed water and juice of other fruits.
EFFECT: breast carcinogenesis inhibition without by-effects.
13 cl, 5 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF BREAST CANCER TREATMENT WITH MORINDA CITRIFOLIA AND METHYLSULPHONYLMETHANE | 2004 |
|
RU2330678C2 |
SELECTIVE INHIBITION OF ESTROGEN PRODUCTION AND ACTIVITY IN HUMAN | 2004 |
|
RU2324372C2 |
COMPOSITION AND METHODS OF CARE OF ORAL CAVITY BASED ON MORINDA CITRIFOLIA | 2004 |
|
RU2324472C2 |
COUNTER-FUNGUS PREPARATIONS BASED ON MORINDA CITRIFOLIA, AND TREATMENT METHODS | 2006 |
|
RU2366179C2 |
FLAVONONE-CONTAINING COMPOSITION FOR SKIN, HAIR AND ANIMAL FUR IMPROVEMENT | 2004 |
|
RU2355378C2 |
COMPOSITION CONTAINING Actinidia AND METHODS OF THEIR APPLICATION | 2006 |
|
RU2423139C2 |
APPLICATION OF ALLOPURINOL FOR TREATING PALMOPLANTAR ERYTHRODYSESTHESIA | 2007 |
|
RU2438673C2 |
SKIN REGENERATION COMPOSITION AND METHOD | 2010 |
|
RU2532343C2 |
METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
USE OF CREATINE PHOSPHATE FOR TREATMENT OF TUMORS AND PHARMACEUTICAL PREPARATIONS SHOWING ANTITUMOR ACTIVITY | 1992 |
|
RU2097040C1 |
Authors
Dates
2009-02-20—Published
2004-08-11—Filed